Skip to main content
Premium Trial:

Request an Annual Quote

Genomics Ltd. Raises $12.8M in Private Financing

NEW YORK (GenomeWeb) – Genomics Ltd. has raised £10.3 million ($12.8 million) in a private round of financing, according to a statement released today by one of its investors, the IP Group.

The firm, which is a spinout from the University of Oxford in the UK, is developing a platform for genomic sequence data analysis. Its founders include Oxford Professors Peter Donnelly, who also is director of the Wellcome Trust Centre for Human Genetics, and Gil McVean. It is chaired by David Norwood, who was one of the founders of Oxford Nanopore Technologies.

Investors in the round included the IP Group and the University of Oxford, as well as new investors Invesco Perpetual, Lansdowne Partners, Woodford Investment Management and the Wylie Family Trust. The IP Group said that its nearly 17 percent stake in Genomics Ltd. is valued at £4.3 million, and including the holdings of an affiliated fund its effective beneficial interest in the firm is approximately 19 percent.

Last month, Genomics Ltd. was one of 10 firms selected to continue to the next assessment phase of the UK's 100,000 Genomes Project.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.